BioNTech jumps to third. BIG THREE DOMINATING - Total return stays at 178%

Novavax had another terrible week, with its return falling a full 123% down to 1198%. It is still #1 by a mile. However, the other two big boys (Moderna and this week particularly, BioNTech) are establishing themselves as the go-to COVID VACCINE STOCKS. BioNTech roared up to third overall with an average return gain of 61%. 

The average returns of all 27 stocks remained static with a return of 178%. This masks some serious moves within the group.

For example, Arcturus had a poor week, with its return falling 30% down to 161%. It fell out of the TOP TEN to be replaced by Heat Biologics which had its return gained another 11% up to 197%.